Biocon reports a fall in quarterly net profit while revenue from operations increases year-on-year. Business Line says Q2 net profit drops 57.3% to ₹56.7 crore, with total income rising to ₹4,423.4 crore even as total expenses also increase to ₹4,361.9 crore.
NDTV reports a profit decline of about half: net profit falls 51% to around ₹41 crore, while consolidated revenue from operations rises 2.2% year-on-year to about ₹4,389 crore. NDTV also breaks down performance by segment, citing biosimilars revenue up about 3% to ₹2,809 crore and generics revenue up about 10% to roughly ₹774 crore. NDTV’s second item further notes that Biocon’s results miss estimates.
Across outlets, the broad direction matches: profit declines in Q2 while revenue grows slightly, alongside increases in key business segments. Differences mainly appear in the exact profit and revenue figures cited and the degree of emphasis placed on whether expectations were met.
